(±)-CBCQ, or (±)-cis-3-(4-chlorobenzyl)-2-oxazolidinone, is a chemical compound characterized by its oxazolidinone structure, which features a five-membered ring containing both nitrogen and oxygen atoms. This compound typically exhibits properties associated with its functional groups, including potential solubility in organic solvents and moderate stability under standard conditions. The presence of the chlorobenzyl group may impart specific reactivity and biological activity, making it of interest in medicinal chemistry and pharmacology. As a racemic mixture, (±)-CBCQ contains equal amounts of both enantiomers, which can exhibit different biological activities. Its applications may extend to research in drug development, particularly in the context of antimicrobial or anti-inflammatory agents. However, detailed studies on its pharmacokinetics, toxicity, and specific applications are necessary to fully understand its potential uses and safety profile. As with any chemical substance, proper handling and safety protocols should be observed when working with (±)-CBCQ.

(±)-CBCQ

2415352-36-0: (±)-CBCQ, or (±)-cis-3-(4-chlorobenzyl)-2-oxazolidinone, is a chemical compound characterized by its oxazolidinone structure, which features a five-membered ring containing both nitrogen and oxygen atoms. This compound typically exhibits properties associated with its functional groups, including potential solubility in organic solvents and moderate stability under standard conditions. The presence of the chlorobenzyl group may impart specific reactivity and biological activity, making it of interest in medicinal chemistry and pharmacology. As a racemic mixture, (±)-CBCQ contains equal amounts of both enantiomers, which can exhibit different biological activities. Its applications may extend to research in drug development, particularly in the context of antimicrobial or anti-inflammatory agents. However, detailed studies on its pharmacokinetics, toxicity, and specific applications are necessary to fully understand its potential uses and safety profile. As with any chemical substance, proper handling and safety protocols should be observed when working with (±)-CBCQ.

<p>(±)-CBCQ, an oxidation product of cannabidiol, exhibits an EC50 value of 14.7 μM for the activation of peroxisome proliferator-activated receptor γ (PPAR-γ).</p>

CAS 2415352-36-0

(±)-CBCQ

(±)-CBCQ

Ref: TM-T203263